Bone marrow mononuclear cell transplantation had beneficial effects on doxorubicin-induced cardiomyopathy
- 30 April 2004
- journal article
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 23 (4) , 436-445
- https://doi.org/10.1016/s1053-2498(03)00220-1
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Repair of Infarcted Myocardium by Autologous Intracoronary Mononuclear Bone Marrow Cell Transplantation in HumansCirculation, 2002
- Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trialThe Lancet, 2002
- Angiogenesis by endothelial cell transplantationThe Journal of Thoracic and Cardiovascular Surgery, 2001
- Intracoronary Infusion of Skeletal Myoblasts Improves Cardiac Function in Doxorubicin-Induced Heart FailureCirculation, 2001
- Implantation of Bone Marrow Mononuclear Cells Into Ischemic Myocardium Enhances Collateral Perfusion and Regional Function via Side Supply of Angioblasts, Angiogenic Ligands, and CytokinesCirculation, 2001
- Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemiaJournal of the American College of Cardiology, 2001
- Myoblast transplantation for heart failureThe Lancet, 2001
- Angiogenesis Induced by the Implantation of Self-Bone Marrow Cells: A New Material for Therapeutic AngiogenesisCell Transplantation, 2000
- Successful Launch of Cardiac Transplantation in JapanJapanese Circulation Journal, 2000
- Echocardiographic and cardiac doppler assessment of miceJournal of the American Society of Echocardiography, 1995